Material and Methods. Twenty-five female patients followed for thalassaemia major constituted the study population. Sexual maturation and hormonal status were assessed. Pubertal and menstrual problems were investigated.Results. There was one patient with delayed puberty and five patients with arrested puberty. Mean ferritin level in this group of patients was slightly but not significantly higher than patients with normal pubertal maturation (2620 +/- 994 ng/ml vs. 2409 +/- 1348 ng/ml, p > 0.05). There were 10 patients with primary amenorrhoea, three with secondary amenorrhoea, five with oligomenorrhoea and irregular menstruation and one with regular menstruation. Compared to menstruating patients, the mean uterine size was smaller (4.1 +/-...
PubMed ID: 11866338Thirty-seven patients with thalassemia major (TM) were studied to determine the e...
Gonadotrophin-hormone-releasing-hormone-Gonadotrophin hormone (GnRH-GTH) secretory dynamics of 30 fe...
We studied bone mass and metabolism in 30 adult women (age 28.5 +/- 1.3) with thalassemia major (TM)...
Material and Methods. Twenty-five female patients followed for thalassaemia major constituted the st...
Endocrine dysfunction in Thalassaemia major (TM) is a common and disturbing complication, which requ...
AbstractDespite recent advances in iron chelation therapy, excess iron deposition in pituitary gonad...
Background: Present transfusion protocols have increased the life expectancy of patients with β-thal...
Abstract: It is estimated that endocrine abnormalities are present in thalasaemic patients. Despite ...
Background: Multi-transfused thalassemia major (TM) patients frequently develop severe endocrine com...
Background: Multi-transfused thalassemia major (TM) patients frequently develop severe endocrine com...
Although transfusions and chelation therapy have improved survival of patients afflicted with Thalas...
Background: The absence of secondary sexual characteristics are known complications in patients with...
Although transfusions and chelation therapy have improved survival of patients afflicted with Thala...
Background: Menarche is an important milestone in a feminine reproductive life, and regular menstrua...
Objective: To determine the prevalence and risk factors of hypogonadotropic hypogonadism in transfus...
PubMed ID: 11866338Thirty-seven patients with thalassemia major (TM) were studied to determine the e...
Gonadotrophin-hormone-releasing-hormone-Gonadotrophin hormone (GnRH-GTH) secretory dynamics of 30 fe...
We studied bone mass and metabolism in 30 adult women (age 28.5 +/- 1.3) with thalassemia major (TM)...
Material and Methods. Twenty-five female patients followed for thalassaemia major constituted the st...
Endocrine dysfunction in Thalassaemia major (TM) is a common and disturbing complication, which requ...
AbstractDespite recent advances in iron chelation therapy, excess iron deposition in pituitary gonad...
Background: Present transfusion protocols have increased the life expectancy of patients with β-thal...
Abstract: It is estimated that endocrine abnormalities are present in thalasaemic patients. Despite ...
Background: Multi-transfused thalassemia major (TM) patients frequently develop severe endocrine com...
Background: Multi-transfused thalassemia major (TM) patients frequently develop severe endocrine com...
Although transfusions and chelation therapy have improved survival of patients afflicted with Thalas...
Background: The absence of secondary sexual characteristics are known complications in patients with...
Although transfusions and chelation therapy have improved survival of patients afflicted with Thala...
Background: Menarche is an important milestone in a feminine reproductive life, and regular menstrua...
Objective: To determine the prevalence and risk factors of hypogonadotropic hypogonadism in transfus...
PubMed ID: 11866338Thirty-seven patients with thalassemia major (TM) were studied to determine the e...
Gonadotrophin-hormone-releasing-hormone-Gonadotrophin hormone (GnRH-GTH) secretory dynamics of 30 fe...
We studied bone mass and metabolism in 30 adult women (age 28.5 +/- 1.3) with thalassemia major (TM)...